Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.29
-0.13 (-2.31%)
Mar 9, 2026, 1:41 PM EDT - Market open
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $171.88 million as of March 9, 2026. Its market cap has increased by 32.63% in one year.
Market Cap
171.88M
Enterprise Value
46.98M
1-Year Change
32.63%
Ranking
Category
Stock Price
$5.29
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $171.88M, a decrease of -51.56%. That is a compound annual growth rate of -23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 175.94M | -8.61% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 183.66M |
| Heron Therapeutics | 182.24M |
| SAB Biotherapeutics | 180.43M |
| Cartesian Therapeutics | 178.12M |
| Nkarta | 177.57M |
| Tiziana Life Sciences | 177.40M |
| Vaxart | 177.33M |
| Whitehawk Therapeutics | 176.73M |